TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7536208

Group type: EXPERIMENTAL
Intervention: Sulfonylureas alone
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Sulfonylureas plus insulin
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Once daily insulin
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Multiple insulin injections
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Sulfonylurea therapy
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Metformin treatment
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 61
Study: 2389112

Group type: EXPERIMENTAL
Intervention: Magnesium pyrrolidone carboxylate
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 7032642

Group type: EXPERIMENTAL
Intervention: Pre-operative serum antisperm antibody titre of 512 or more
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Pre-operative serum antisperm antibody titre below 512
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Presence of seminal plasma antibodies
Number of subjects: 130

Group type: COMPARATOR
Intervention: Per-operative steroids (randomised controlled trial)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Overall pregnancy rate in partners of men trying to conceive
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Sperm-agglutinating antibodies in serum
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Seminal plasma antibodies before reversal
Number of subjects: 130
Study: 31780177

Group type: COMPARATOR
Intervention: Distance from residence to motor vehicle traffic (≥150 m)
Number of subjects: 616

Group type: EXPERIMENTAL
Intervention: Renovated home
Number of subjects: 616

Group type: EXPERIMENTAL
Intervention: Air freshener use
Number of subjects: 616

Group type: EXPERIMENTAL
Intervention: Moldy walls
Number of subjects: 616

Group type: EXPERIMENTAL
Intervention: Humidifier use
Number of subjects: 616
Study: 31260511

Group type: EXPERIMENTAL
Intervention: Cluster randomized trials (CRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Community and ICU infection prevention interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomization by cluster
Number of subjects: 0
Study: 28115830

Group type: EXPERIMENTAL
Intervention: ibuprofen arginine
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: solubilized ibuprofen capsule
Number of subjects: 36

Group type: COMPARATOR
Intervention: standard ibuprofen
Number of subjects: 36
Study: 25655878

Group type: EXPERIMENTAL
Intervention: Physical fitness parameters (aerobic capacity, anaerobic threshold, anaerobic capacity, isometric and functional muscle strength) in children with bilateral CP
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Physical fitness parameters in children with unilateral CP
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Physical fitness in children with CP
Number of subjects: 46
Study: 25697431

Group type: EXPERIMENTAL
Intervention: Birth experience
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control
Number of subjects: 127
Study: 22111824

Group type: EXPERIMENTAL
Intervention: Needles placed 2.5 cm apart
Number of subjects: 12

Group type: COMPARATOR
Intervention: Needles placed 5 cm apart
Number of subjects: 12
Study: 19406886

Group type: EXPERIMENTAL
Intervention: Perindopril and indapamide
Number of subjects: 1709
Study: 17578311

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture at the right Hegu point (L14)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Non-acupoint facial points (control group)
Number of subjects: 14
Study: 16678450

Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study: 12686336

Group type: EXPERIMENTAL
Intervention: Orlistat plus a reduced calorie diet (30% of calories from fat)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diet-only treatment
Number of subjects: 0
Study: 10226960

Group type: EXPERIMENTAL
Intervention: Arthroscopic surgery
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Supervised exercises
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo (detuned soft laser)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Surgery (including all patients who underwent operation)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Pain medication status before surgery
Number of subjects: 125
Study: 8905804

Group type: EXPERIMENTAL
Intervention: Zopiclone 7.5 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 1813203

Group type: EXPERIMENTAL
Intervention: Over-the-counter mouthrinses (specific products not detailed)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group (specific product not detailed)
Number of subjects: 122
Study: 6613474

Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 38

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 38
Study: 29499287

Group type: EXPERIMENTAL
Intervention: Adalimumab (40 mg subcutaneous injections every other week)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo (identical injections)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 27465383

Group type: EXPERIMENTAL
Intervention: Infant formula milk (IFM) containing 10.5 μg I/100 kcal
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Infant formula milk (IFM) containing 19.3 μg I/100 kcal
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Infant formula milk (IFM) containing 38.5 μg I/100 kcal
Number of subjects: 11
Study: 25687352

Group type: EXPERIMENTAL
Intervention: Higher-dose edoxaban
Number of subjects: 21105

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 21105

Group type: EXPERIMENTAL
Intervention: Lower-dose edoxaban
Number of subjects: 21105
Study: 23715771

Group type: EXPERIMENTAL
Intervention: Routine contrast-enhanced abdominal CT (n=143)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Selective imaging practice (SIP) (n=111)
Number of subjects: 300
Study: 20720259

Group type: EXPERIMENTAL
Intervention: 2.0 mg GLP-1
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1.0 mg PYY3-36
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 2.0 mg GLP-1 plus 1.0 mg PYY3-36
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (delivery agent alone)
Number of subjects: 12
Study: 18789007

Group type: EXPERIMENTAL
Intervention: Acridilol for 24 weeks with other antihypertensive therapy (n=291)
Number of subjects: 592

Group type: COMPARATOR
Intervention: Stable antihypertensive therapy for 24 weeks (Control group, n=301)
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Acridilol therapy
Number of subjects: 592

Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 592
Study: 15991507

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.125% with 1:200000 epinephrine, 20 mL administered through a subphrenic catheter before incision closure and at 4-hourly intervals for the first postoperative 20 hours.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline with 1:200000 epinephrine, 20 mL administered through a subphrenic catheter before incision closure and at 4-hourly intervals for the first postoperative 20 hours.
Number of subjects: 0
Study: 12182251

Group type: EXPERIMENTAL
Intervention: Losartan 100 mg/hydrochlorothiazide 25 mg (L100/25)
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg/hydrochlorothiazide 12.5 mg (L50/12.5)
Number of subjects: 446

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 446
Study: 10482058

Group type: EXPERIMENTAL
Intervention: Bordetella pertussis (single agent)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Bordetella parapertussis (single agent)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Chlamydia pneumoniae (single agent)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Mycoplasma pneumoniae (single agent)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: No aetiology found
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Bordetella pertussis (in children with cough for more than 100 days)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Acellular vaccines
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 155
Study: 8974212

Group type: EXPERIMENTAL
Intervention: Procedure predicting average LDL cholesterol based on serial measurements
Number of subjects: 0

Group type: COMPARATOR
Intervention: National Cholesterol Education Program recommendation
Number of subjects: 0
Study: 1751431

Group type: EXPERIMENTAL
Intervention: Antenatal social support programme (expressive emotional support through home visits and telephone calls by midwives)
Number of subjects: 1970

Group type: COMPARATOR
Intervention: Normal antenatal care (Control group)
Number of subjects: 1970
Study: 7055344

Group type: EXPERIMENTAL
Intervention: Real acupuncture therapy
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo treatments
Number of subjects: 43
Study: 31709460

Group type: EXPERIMENTAL
Intervention: Dietary cobalt supplementation (0.5-3 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary cobalt supplementation (up to 2 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary cobalt supplementation (3 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary cobalt supplementation (highest level)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary cobalt supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2 mg/kg Co dietary supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher levels of dietary cobalt
Number of subjects: 0
Study: 31455473

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (15 mg twice daily for 21 days followed by 20 mg once daily)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Warfarin (heparin for 3 to 5 days followed by warfarin for 3 to 6 months)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 151
Study: 28604652

Group type: EXPERIMENTAL
Intervention: Intramedullary nailing guided by digital technology
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional technology
Number of subjects: 32
Study: 26346311

Group type: EXPERIMENTAL
Intervention: Food Access Survey Tool (FAST)
Number of subjects: 11992
Study: 23589565

Group type: EXPERIMENTAL
Intervention: Dietary nitrate (≈ 3.5 mmol)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Xanthine oxidoreductase (XOR) inhibitor, allopurinol
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Nitrite in spontaneously hypertensive rats
Number of subjects: 15
Study: 22080312

Group type: EXPERIMENTAL
Intervention: Bodypump training (n = 9)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (n = 10)
Number of subjects: 19
Study: 19109588

Group type: EXPERIMENTAL
Intervention: Nocturnal hemodialysis
Number of subjects: 52

Group type: COMPARATOR
Intervention: Conventional hemodialysis
Number of subjects: 52
Study: 17885936

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Former smokers
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Never smokers
Number of subjects: 251

Group type: COMPARATOR
Intervention: Nonsmokers with environmental tobacco smoke exposure
Number of subjects: 251
Study: 12643888

Group type: EXPERIMENTAL
Intervention: Bisoprolol low dose (1.25, 2.5 or 3.75mg/day)
Number of subjects: 2647

Group type: EXPERIMENTAL
Intervention: Bisoprolol moderate dose (5 or 7.5mg/day)
Number of subjects: 2647

Group type: EXPERIMENTAL
Intervention: Bisoprolol high dose (10mg/day)
Number of subjects: 2647

Group type: EXPERIMENTAL
Intervention: Bisoprolol (all doses)
Number of subjects: 2647

Group type: COMPARATOR
Intervention: Placebo low dose
Number of subjects: 2647

Group type: COMPARATOR
Intervention: Placebo moderate dose
Number of subjects: 2647

Group type: COMPARATOR
Intervention: Placebo high dose
Number of subjects: 2647
Study: 10777470

Group type: EXPERIMENTAL
Intervention: Paclitaxel in combination with cisplatin or carboplatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Docetaxel in combination with cisplatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etoposide/cisplatin (previous standard regimen)
Number of subjects: 0
Study: 9175967

Group type: EXPERIMENTAL
Intervention: Adrenaline 0.1 microgram kg‐1 min‐1
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Dobutamine 5 micrograms kg‐1 min‐1
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Dopexamine 2 micrograms kg‐1 min‐1
Number of subjects: 6

Group type: COMPARATOR
Intervention: 5% glucose 0.5 ml kg‐1 h‐1
Number of subjects: 6
Study: 1416572

Group type: EXPERIMENTAL
Intervention: Subcutaneous octreotide, 100 micrograms every 8 hours for 4 weeks
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: 300 micrograms of octreotide daily for 6 months
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: 750 micrograms of octreotide daily for 6 months
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 115
Study: 4014015

Group type: EXPERIMENTAL
Intervention: Caffeine (3.3 mg/kg body weight, equivalent to 2 to 3 cups of coffee)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 30925958

Group type: EXPERIMENTAL
Intervention: Montelukast combined with Budesonide
Number of subjects: 112

Group type: COMPARATOR
Intervention: Budesonide
Number of subjects: 112
Study: 28440001

Group type: EXPERIMENTAL
Intervention: tDCS + PES
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: PES alone
Number of subjects: 92

Group type: COMPARATOR
Intervention: tDCS alone
Number of subjects: 92

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 92
Study: 26027224

Group type: EXPERIMENTAL
Intervention: Usual intensive therapy (IT)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Differentiated therapy for improvement of renal function
Number of subjects: 63
Study: 23151596

Group type: EXPERIMENTAL
Intervention: mail‐in questionnaire/live telephone interviews (MIP)
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: automated telephone with interactive voice recognition
Number of subjects: 640

Group type: COMPARATOR
Intervention: internet‐based computer Kiosk
Number of subjects: 640
Study: 21898603

Group type: EXPERIMENTAL
Intervention: Resilience-oriented intervention
Number of subjects: 39

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 39
Study: 19546826

Group type: EXPERIMENTAL
Intervention: BZA 20 mg/CE 0.45 mg
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: BZA 20 mg/CE 0.625 mg
Number of subjects: 332

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 332
Study: 17414346

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 245

Group type: COMPARATOR
Intervention: Control
Number of subjects: 245
Study: 15224162

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1000 mg administered intravenously 5 min before surgery)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no tranexamic acid)
Number of subjects: 40
Study: 11213000

Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 369

Group type: COMPARATOR
Intervention: Non-epidural analgesia
Number of subjects: 369
Study: 9871930

Group type: EXPERIMENTAL
Intervention: Fick's law with oxygen (FiO2)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Fick's law with inert gases (FiIG)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Thermodilution (TH)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Echocardiography (E)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Calculated based on biometrical data (C)
Number of subjects: 11
Study: 7885802

Group type: EXPERIMENTAL
Intervention: Moving stimulus figures at 20 cm/sec
Number of subjects: 5

Group type: COMPARATOR
Intervention: Stationary stimulus figures
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Moving slowly at 10 cm/sec
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Moving fast at 30 cm/sec
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Stimuli moving at speeds ranging from 0 to 45 cm/sec
Number of subjects: 5
Study: 1978680

Group type: EXPERIMENTAL
Intervention: Mepindolol TSD
Number of subjects: 14

Group type: COMPARATOR
Intervention: Transdermal nitrate
Number of subjects: 14
Study: 95482

Group type: COMPARATOR
Intervention: Norpace (disopyramide phosphate)
Number of subjects: 120
Study: 31588026

Group type: EXPERIMENTAL
Intervention: E-mail alert sent to physician
Number of subjects: 3327

Group type: COMPARATOR
Intervention: No alert (control group)
Number of subjects: 3327
Study: 31009904

Group type: EXPERIMENTAL
Intervention: Real tDCS
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 18
Study: 28189361

Group type: EXPERIMENTAL
Intervention: Bremelanotide (20 mg) with ethanol (0.6 g/kg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Bremelanotide (20 mg) without ethanol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 25456099

Group type: EXPERIMENTAL
Intervention: Intensive glucose treatment
Number of subjects: 1724

Group type: COMPARATOR
Intervention: Standard glucose treatment
Number of subjects: 1724
Study: 23812832

Group type: EXPERIMENTAL
Intervention: Procovery intervention (facilitated mutual support group)
Number of subjects: 0
Study: 21451354

Group type: EXPERIMENTAL
Intervention: Judges with high clinical experience (experts)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Judges with low clinical experience (novices)
Number of subjects: 30
Study: 19152943

Group type: EXPERIMENTAL
Intervention: Active ankle positions (plantar position with raised arms)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Passive ankle positions
Number of subjects: 31

Group type: COMPARATOR
Intervention: Horizontal foot position
Number of subjects: 31
Study: 16813778

Group type: EXPERIMENTAL
Intervention: Modified Shuttle Walk Test (MSWT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Estimated Vo2max from MSWT
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Test-retest reliability of MSWT
Number of subjects: 30
Study: 12950538

Group type: EXPERIMENTAL
Intervention: ICD therapy
Number of subjects: 449
Study: 10668944

Group type: EXPERIMENTAL
Intervention: Single dose oral ofloxacin
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Single dose oral trimethoprim-sulfamethoxazole
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (no prophylaxis)
Number of subjects: 110
Study: 8537804

Group type: EXPERIMENTAL
Intervention: OCPs with a BSE prompt
Number of subjects: 907

Group type: COMPARATOR
Intervention: Regularly packaged OCPs (without BSE prompt)
Number of subjects: 907
Study: 1898998

Group type: EXPERIMENTAL
Intervention: Intravenous flecainide (2 mg/kg, maximum dose 150 mg) with digoxin (500 micrograms)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo with digoxin (500 micrograms)
Number of subjects: 102
Study: 7202238

Group type: EXPERIMENTAL
Intervention: Dexedrine 2.5 mg twice daily
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dexedrine 5 or 10 mg twice daily
Number of subjects: 10
Study: 3887910

Group type: EXPERIMENTAL
Intervention: Stress management
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Mutual support
Number of subjects: 105

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 105
Study: 29205809

Group type: EXPERIMENTAL
Intervention: Soft silicone-coated wound contact layer (Mepitel One)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Lipidocolloid wound contact layer (UrgoTul)
Number of subjects: 121
Study: 27030648

Group type: EXPERIMENTAL
Intervention: Blood purification group (BP) received continuous venous‐venous hemodiafiltration in addition to conventional treatment.
Number of subjects: 41
Study: 24886225

Group type: EXPERIMENTAL
Intervention: Telehealthcare intervention
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Usual practice (control)
Number of subjects: 1200
Study: 22236918

Group type: EXPERIMENTAL
Intervention: 3-monthly home visits for questionnaire-based TB screening plus record surveillance of TB registers, hospital admission and X-ray lists at health facilities for TB suspects and cases (Group 1)
Number of subjects: 4786

Group type: COMPARATOR
Intervention: Record surveillance only (Group 2)
Number of subjects: 4786

Group type: EXPERIMENTAL
Intervention: Group 1
Number of subjects: 4786

Group type: COMPARATOR
Intervention: Group 2
Number of subjects: 4786
Study: 19415341

Group type: EXPERIMENTAL
Intervention: 750 mg/day American ginseng
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: 1,000 mg/day American ginseng
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: 2,000 mg/day American ginseng
Number of subjects: 290

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 290
Study: 18560878

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) for 6 weeks, pressure-threshold IMT
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group, no IMT
Number of subjects: 22
Study: 15724142

Group type: EXPERIMENTAL
Intervention: DAT1 gene influence on caudate volume
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DRD4 gene influence on prefrontal gray matter volume
Number of subjects: 0
Study: 14601350

Group type: EXPERIMENTAL
Intervention: Questionnaires disclosed and scored by GPs
Number of subjects: 1785

Group type: COMPARATOR
Intervention: Questionnaires blinded
Number of subjects: 1785
Study: 10645192

Group type: EXPERIMENTAL
Intervention: Dual energy X-ray absorptiometry (DXA) of the calcaneus
Number of subjects: 55
Study: 8762416

Group type: EXPERIMENTAL
Intervention: Buqi Qiangxin decoction (BQQXD)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Verapamil
Number of subjects: 52
Study: 1707795

Group type: EXPERIMENTAL
Intervention: Electroencephalogram (EEG)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Somatosensory evoked potentials (SEPs)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Comparison of EEG and SEPs
Number of subjects: 90
Study: 6619669

Group type: EXPERIMENTAL
Intervention: Prone leg length-differential test measured by three experienced chiropractic clinicians
Number of subjects: 40
Study: 30765407

Group type: EXPERIMENTAL
Intervention: Surgical spinal decompression
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo surgical intervention
Number of subjects: 160
Study: 29957099

Group type: EXPERIMENTAL
Intervention: Dried apple
Number of subjects: 21

Group type: COMPARATOR
Intervention: Muffins
Number of subjects: 21